Research is ongoing to better understand the full potential of sotorasib in treating various cancers. Future studies are focusing on combination therapies, where sotorasib is used alongside other drugs to enhance its efficacy. There is also interest in identifying biomarkers that can predict which patients are most likely to benefit from sotorasib treatment. Additionally, researchers are exploring ways to overcome resistance mechanisms that some tumors develop against sotorasib.
